Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences Subscribe to our YouTube channel for the latest MadeAi product updates
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

106 articles published Follow:
lr

Life Science Professionals’ Perspectives on AI: Insights from CapeStart’s GenAI Report

BlogDecember 10, 2024222Views0Likes0Comments
Artificial Intelligence (AI) is making waves in industries worldwide, but how do professionals in life sciences feel about its potential? According to CapeStart’s Life Science AI Research Report, a resounding 91% of respondents believe that AI can assist and empower their work. This overwhelming optimism highlights a strong recognition of AI’s transformative capabilities. Belief in…

Read More

How CapeStart Streamlined Literature Review at Top 20 Pharmaceutical Manufacturer with GenAI-enabled Solution

CapeStart’s GenAI Solution Streamlines Literature Review for Top 20 Pharmaceutical Manufacturer

Case StudyDecember 2, 2024299Views0Likes0Comments
The clinical team for existing products at “ABC Pharma,” a top 20 pharmaceutical manufacturer, needed an automated solution for processing large volumes of medical literature across multiple therapeutic areas. Their internal development efforts had proved costly and unsuccessful. Requiring a comprehensive platform that could handle diverse literature types, support Health Authority inquiries, process content across ten…

Read More

How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

Case StudyNovember 15, 2024275Views0Likes0Comments
A leading biotech company, faced critical challenges in their regulatory submission process. They needed to conduct a comprehensive clinical literature review and create a Clinical Evaluation Report (CER) with limited time and resources. The biotech company turned to CapeStart, who provided a hybrid approach combining expert analysis with their GenAI-powered MadeAi™ platform for literature review. Check-out…

Read More

CapeStart's Literature Review Research Report

CapeStart’s Literature Review Research Report

Case StudyNovember 1, 2024935Views0Likes0Comments
CapeStart's Literature Review Research Report examines how life sciences professionals approach literature reviews, exploring their methodologies, challenges, and resource allocation between internal and external teams. The study investigates key aspects including goals, scope, complexity management, and success metrics, while also analyzing information sources and professional associations, along with demographic data from survey respondents.

Read More